Tango Therapeutics, Inc.
TNGX
$1.29
$0.010.78%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -130.30M | -123.40M | -116.49M | -111.65M | -101.74M |
| Total Depreciation and Amortization | 2.50M | 2.50M | 2.49M | 2.46M | 2.42M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.05M | 23.93M | 23.53M | 21.37M | 19.31M |
| Change in Net Operating Assets | -31.75M | -25.35M | -29.59M | -33.11M | -37.97M |
| Cash from Operations | -131.50M | -122.32M | -120.07M | -120.93M | -117.98M |
| Capital Expenditure | -754.00K | -856.00K | -757.00K | -1.10M | -1.53M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 86.88M | 68.77M | -20.56M | -227.00K | 42.95M |
| Cash from Investing | 86.13M | 67.92M | -21.32M | -1.33M | 41.43M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 47.66M | 48.40M | 126.28M | 125.56M | 82.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -241.00K | -241.00K | -241.00K | -241.00K |
| Cash from Financing | 47.66M | 48.16M | 126.04M | 125.32M | 82.41M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.29M | -6.24M | -15.34M | 3.06M | 5.85M |